Insulin resistance often has no obvious symptoms. Possible clues include a growing waist size, difficulty losing weight, dark velvety skin patches, skin tags, high blood pressure, abnormal cholesterol, PCOS, fatty liver disease, or blood sugar in the prediabetes range. The only way to understand your risk is through a clinician review and blood testing 1.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What are the most common signs of insulin resistance?
Insulin resistance is often quiet, so the “signs” are usually patterns rather than a single symptom. The most useful clues are body changes, skin findings, and lab changes that suggest higher metabolic risk over months to years 1.
Why many people have no symptoms at first
Early on, the pancreas may make extra insulin, called hyperinsulinemia, to keep blood glucose in range. That means a person can have insulin resistance before fasting glucose or A1C becomes abnormal 1.
Body and skin clues: waist size, acanthosis nigricans, and skin tags
A larger waist can reflect more visceral fat, the deeper belly fat linked with insulin resistance and metabolic syndrome 2. Dark, thick, velvety patches of skin, called acanthosis nigricans, and skin tags can also be associated with insulin resistance, especially when they appear on the neck, armpits, or groin 1.
Energy and appetite clues: post-meal fatigue and cravings
Some people notice post-meal sleepiness, hunger soon after eating, or stronger carbohydrate cravings. These symptoms are common and nonspecific, so they can be caused by sleep, stress, food timing, medications, depression, thyroid disease, anemia, or high blood sugar rather than insulin resistance alone 1.
Lab clues: rising glucose, triglycerides, blood pressure, or A1C
Lab and vital-sign patterns can be more useful than symptoms. Fasting glucose, A1C, oral glucose tolerance test results, triglycerides, HDL cholesterol, and blood pressure help clinicians assess prediabetes, type 2 diabetes risk, dyslipidemia, hypertension, and metabolic syndrome 1.
What does insulin resistance feel like?
Insulin resistance may feel like nothing at all. When symptoms are present, they are usually indirect clues, and one symptom cannot tell you whether insulin signaling is the problem 1.
Why insulin resistance may feel like nothing
Insulin helps move glucose from the bloodstream into muscle, fat, and liver cells. If those cells respond less well, the pancreas can often compensate for a time by making more insulin, so blood glucose may stay normal and symptoms may be absent 1.
When fatigue, cravings, or weight changes may be worth discussing
Fatigue, cravings, and gradual weight gain are worth discussing when they occur with a larger waist, PCOS, sleep apnea, high blood pressure, abnormal lipids, fatty liver disease, or a family history of type 2 diabetes. We also suggest reading our deeper guide to insulin resistance and diabetes if you are trying to understand the long-term risk.
Symptoms that may point to high blood sugar instead
Thirst, frequent urination, blurry vision, unintentional weight loss, nausea, vomiting, confusion, or dehydration can point to high blood sugar and need prompt medical attention. Type 2 diabetes can affect the heart, eyes, kidneys, nerves, and other organs when blood glucose stays high over time 1.
What causes insulin resistance?
Insulin resistance develops when insulin signaling becomes less effective in key tissues. Genetics, visceral fat, inactivity, aging, sleep disorders, endocrine conditions, smoking, inflammation, and some medications can all contribute over time 1.
How insulin normally helps move glucose into cells
Insulin is a hormone made by the pancreas. After you eat, insulin helps move glucose from blood into cells so the body can use or store energy 1.
Why muscle, fat, and liver cells may respond less well to insulin
Research links insulin resistance to changes in insulin receptors, inflammation, lipotoxicity, liver metabolism, mitochondrial function, and other cell-signaling pathways. In plain language, the message from insulin does not land as well, so the pancreas may need to send a louder signal 2.
Risk factors: waist size, inactivity, age, family history, smoking, PCOS, sleep apnea, and certain medications
Risk factors include overweight or obesity, large waist size, age 35 or older, family history of diabetes, physical inactivity, smoking, history of gestational diabetes, PCOS, Cushing’s syndrome, acromegaly, sleep apnea, and long-term use of certain medicines such as glucocorticoids or some antipsychotic medications 1.
How is insulin resistance different from prediabetes?
Insulin resistance is a body process; prediabetes is a blood sugar diagnosis. A person can have insulin resistance with normal glucose if the pancreas is still able to compensate 1.
Insulin resistance as an early process
Insulin resistance can begin before routine blood sugar tests cross into the prediabetes range. That is why waist size, triglycerides, blood pressure, family history, PCOS, and sleep apnea can matter even when glucose looks normal 1.
Prediabetes as a blood sugar diagnosis
Prediabetes means blood glucose is higher than normal but not high enough for type 2 diabetes. Clinicians commonly use A1C, fasting glucose, or an oral glucose tolerance test to diagnose it 1.
Why a person can have insulin resistance with normal glucose
If the pancreas can produce enough insulin, glucose may stay in range. Over time, if the pancreas cannot keep up, glucose can rise into prediabetes or type 2 diabetes range 1. For a side-by-side explanation, see our guide to diabetes vs. insulin resistance.
How can you check for insulin resistance at home?
You cannot prove insulin resistance at home. You can track clues such as waist size, blood pressure, weight trend, and symptoms, then bring that pattern to a clinician for lab testing 1.
What you can track at home: waist size, blood pressure, weight trend, and symptoms
Useful home tracking can include waist measurement, blood pressure readings, weight trend, sleep quality, activity, smoking status, menstrual patterns, and symptoms after meals. These do not diagnose insulin resistance, but they help a clinician decide what to test 1.
Why home glucose checks do not prove or rule out insulin resistance
A normal home glucose reading does not rule out insulin resistance because glucose can stay normal while insulin levels are high. A high home reading also needs confirmation with standard clinical testing 1.
When to ask a clinician about A1C, fasting glucose, lipids, or other testing
Ask about A1C, fasting glucose, an oral glucose tolerance test, lipids, liver enzymes, blood pressure, and screening for PCOS, sleep apnea, or fatty liver disease when risk factors are present. Fasting insulin and HOMA-IR are sometimes discussed, but they are not the main way most clinicians diagnose prediabetes in routine care 1.
The hyperinsulinemic-euglycemic clamp is often described as a gold-standard research method for measuring insulin sensitivity, but it is complex and not practical for routine office care 3.
What health problems are linked with insulin resistance?
Insulin resistance is linked with several metabolic and hormonal conditions. The main concerns are prediabetes, type 2 diabetes, metabolic syndrome, fatty liver disease, PCOS, sleep apnea, hypertension, and dyslipidemia over years 1.
Prediabetes and type 2 diabetes
Insulin resistance can raise the risk of prediabetes and type 2 diabetes when the pancreas cannot keep blood glucose in a healthy range. If you have already been told your glucose is high, our guides on blood sugar levels and diabetes and how to reverse prediabetes may help you prepare for a clinician visit.
Metabolic syndrome and cardiovascular risk
Metabolic syndrome is a cluster that often includes central adiposity, high blood pressure, high triglycerides, low HDL cholesterol, and abnormal glucose. This pattern is linked with higher cardiovascular risk 2.
PCOS and reproductive-health patterns
PCOS can include irregular periods, androgen-related symptoms, and metabolic risk, including insulin resistance. The Endocrine Society guideline recommends evaluating women with PCOS for glucose intolerance and cardiovascular risk factors 4.
Small randomized trials in women with PCOS have studied interventions that may affect insulin-resistance markers, including acetyl-L-carnitine and Vitex agnus-castus, but these data do not apply to every person and should not be used as self-treatment instructions 5, 6.
Fatty liver disease and sleep apnea
Nonalcoholic fatty liver disease, now often called metabolic dysfunction-associated steatotic liver disease, is closely tied to insulin resistance and metabolic risk. Sleep apnea is also listed by NIDDK as a risk factor for insulin resistance and prediabetes 1.
What helps improve insulin resistance?
Lifestyle changes are first-line for most people because they target the drivers of insulin resistance. The strongest practical steps are nutrition changes, regular activity, resistance training, weight loss when appropriate, sleep care, smoking cessation, and medication review over weeks to months 1.
Nutrition patterns with the strongest practical support
A helpful eating pattern usually emphasizes minimally processed foods, fiber-rich carbohydrates, lean protein, healthy fats, and fewer sugar-sweetened drinks. The Diabetes Prevention Program showed that intensive lifestyle change reduced progression to diabetes in high-risk adults; individual results vary 7.
Aerobic activity and resistance training
Physical activity helps muscle use glucose and can improve insulin sensitivity. A mix of aerobic activity and resistance training is often practical because muscle is a major site of glucose disposal 2.
Weight loss when appropriate
For people with overweight or obesity, even modest weight loss can improve glucose and cardiometabolic risk markers. The Diabetes Prevention Program lifestyle intervention aimed for 7% weight loss and at least 150 minutes of physical activity per week in adults at high risk for diabetes; this is a study target, not personal medical advice 7.
Sleep, smoking cessation, and medication review
Sleep apnea, smoking, and certain medications can worsen insulin resistance risk. A clinician can help screen for sleep apnea, support smoking cessation, and review whether glucocorticoids, antipsychotic medications, or other drugs may be affecting metabolic health 1.
When medications may be considered for related conditions
Medication decisions depend on the diagnosis being treated, such as obesity, type 2 diabetes, high blood pressure, dyslipidemia, or PCOS. Metformin reduced diabetes progression in the Diabetes Prevention Program, with the strongest effect in some higher-risk groups, but it is still a clinician-guided decision with possible side effects such as gastrointestinal symptoms and vitamin B12 concerns 7, 8.
| If this sounds like you | Sensible next step | Why it matters |
|---|---|---|
| No symptoms, but family history of type 2 diabetes | Ask about A1C, fasting glucose, lipids, blood pressure, and waist risk | Insulin resistance can be silent before glucose becomes abnormal |
| Dark velvety skin patches, skin tags, or larger waist | Schedule a clinician visit rather than self-diagnosing | Skin and body clues can point to higher metabolic risk but are not diagnostic |
| PCOS, irregular periods, or androgen symptoms | Ask about glucose testing and cardiometabolic risk | PCOS can overlap with insulin resistance and prediabetes risk |
| Prediabetes-range labs | Discuss structured lifestyle support and follow-up testing | Prediabetes is a blood sugar diagnosis that can often improve with early action |
| Overweight or obesity plus metabolic risk | Ask whether weight-loss treatment is appropriate | Medication may fit some people, but eligibility depends on a medical review |
3-min quiz
Considering weight-loss treatment for metabolic risk?
At Chia, eligible patients can be evaluated online for clinician-guided options such as semaglutide injection or tirzepatide tablets or injection. A licensed US provider reviews your health history and prescribes only when clinically appropriate; a prescription is never guaranteed. Compounded medications are not FDA-approved.
When do weight-loss medications fit into insulin resistance care?
Weight-loss medications do not diagnose insulin resistance. They may be considered when a person has obesity or weight-related metabolic risk, and the goal is to address weight, glucose, or cardiometabolic risk under clinician care over ongoing follow-up 9, 10.
Why medications are not used to diagnose insulin resistance
A medication response cannot prove that insulin resistance was present. Testing, history, exam findings, and risk factors are still needed to understand what is driving weight, glucose, triglycerides, blood pressure, or PCOS patterns 1.
How GLP-1 and GIP/GLP-1 medications relate to weight, glucose, and metabolic risk
Wegovy (semaglutide, a GLP-1 receptor agonist; also available as compounded semaglutide through licensed 503A pharmacies) is FDA-approved for chronic weight management in eligible patients and for certain cardiovascular-risk indications on its label. Ozempic and Rybelsus are semaglutide products labeled for type 2 diabetes, not general weight loss 9, 11, 12.
Zepbound (tirzepatide, a dual GIP/GLP-1 receptor agonist; also available as compounded tirzepatide through licensed 503A pharmacies) is FDA-approved for chronic weight management in eligible patients. Mounjaro is a tirzepatide product labeled for type 2 diabetes 10, 13.
These medication classes can cause side effects such as nausea, vomiting, diarrhea, constipation, abdominal pain, and possible gallbladder or pancreatitis concerns, and they have contraindications and warnings that require clinician review. They are not for everyone, including certain patients with relevant endocrine cancer history, pregnancy concerns, or other risks described in labeling 9, 10.
Who may be evaluated for medication based on BMI, diabetes risk, or related conditions
A clinician may evaluate medication eligibility using BMI, weight-related conditions, diabetes risk, current medications, pregnancy status, contraindications, and treatment goals. Using a GLP-1 or GIP/GLP-1 medication specifically for insulin resistance without an approved indication may be off-label, so the decision should be individualized and documented.
Insulin resistance care at Chia: GLP-1 treatment options when weight is part of the picture
Chia treats eligible patients online when weight is part of the metabolic-health picture. Our process is 100% online: you complete a health questionnaire, a licensed US provider reviews it, and medication is prescribed only when clinically appropriate.
Online clinician review and eligibility screening
At Chia, medication eligibility depends on your medical history, labs when needed, contraindications, current medications, pregnancy status, and goals. Our care team can also help patients think through related risks like prediabetes, metabolic syndrome, and weight-related conditions; for background, see our guide to metabolic syndrome and weight loss.
Semaglutide injection at Chia
Chia offers compounded semaglutide injection, with plans currently starting at $249/month. Dosing is provider-guided and adjusted over time; microdosing plans are available when clinically appropriate.
Tirzepatide tablets or injection at Chia
Chia offers compounded tirzepatide tablets or injection. Plans currently start at $249/month for tablets and $299/month for injection, with microdosing plans available when clinically appropriate.
| Chia option | Forms offered | Current starting price | Fit to discuss with a provider |
|---|---|---|---|
| Semaglutide | Injection | From $249/month | May fit eligible patients seeking clinician-guided GLP-1 treatment |
| Tirzepatide | Tablets or injection | Tablets from $249/month; injection from $299/month | May fit eligible patients seeking dual GIP/GLP-1 treatment and a choice of form |
| Weight + Energy protocol | NAD+ injection plus choice of GLP-1 | From $309/month | May fit eligible patients whose provider agrees that weight and energy goals overlap |
| Weight + Muscle protocol | Sermorelin injection plus choice of GLP-1 | From $329/month | May fit eligible patients whose provider agrees that weight and body-composition goals overlap |
Microdosing plans when clinically appropriate
Microdosing at Chia means provider-guided dosing with follow-up, not a do-it-yourself protocol. Patients can message their care team through the portal between visits, and medications are compounded by state-licensed US 503A pharmacies and shipped to the door.
How DoctorMCP can help eligible patients reach Chia through mcp.chia.health
If an AI agent is helping you find a licensed prescription-delivery path, DoctorMCP at mcp.chia.health can route eligible patients toward Chia’s online evaluation. It does not replace clinical review, and a prescription is never guaranteed.
What should you ask a clinician if you think you have insulin resistance?
Clinician questions should focus on testing, risk factors, and what changes are realistic. A short list can help you use a 15-minute visit well.
Questions about labs and risk factors
- Should I have A1C, fasting glucose, an oral glucose tolerance test, or lipid testing?
- Do my waist size, blood pressure, triglycerides, HDL cholesterol, or family history raise my risk?
- Would fasting insulin or HOMA-IR add useful information in my case, or would it not change the plan?
Questions about PCOS, sleep apnea, fatty liver disease, or medications
- Could PCOS, sleep apnea, MASLD or NAFLD, Cushing’s syndrome, acromegaly, or another endocrine issue be part of this pattern?
- Could glucocorticoids, antipsychotic medications, or another long-term medicine be affecting my weight or glucose?
- Do I need liver tests, sleep-apnea screening, or reproductive-health testing?
Questions about weight-loss treatment eligibility
- Am I a candidate for structured lifestyle support, medication, or both?
- What side effects, contraindications, and monitoring would apply to me?
- If I have prediabetes, what follow-up testing schedule makes sense? Our guide to weight loss for prediabetes may help you prepare.
When should you get medical help now?
Urgent symptoms are different from quiet insulin resistance. Seek help now for same-day warning signs such as confusion, dehydration, chest pain, trouble breathing, pregnancy-related concerns, or rapid unexplained weight loss.
Also seek prompt care if you have excessive thirst, frequent urination, vomiting, severe weakness, blurry vision, or very high glucose readings. These can point to high blood sugar or another condition that needs direct medical evaluation 1.
3-min quiz
Start with a clinician-reviewed plan
If weight is part of your insulin-resistance or prediabetes-risk picture, Chia can evaluate whether GLP-1 care is appropriate for you. Options may include semaglutide, tirzepatide, Weight + Energy, or Weight + Muscle, depending on your history and goals. A prescription requires medical evaluation and is not guaranteed; compounded medications are not FDA-approved.
FAQ
Possible clues include a larger waist, difficulty losing weight, dark velvety skin patches, skin tags, high blood pressure, high triglycerides, low HDL cholesterol, rising A1C, prediabetes-range glucose, PCOS, fatty liver disease, and sleep apnea. These clues do not diagnose insulin resistance by themselves.
There is no one-size-fits-all fix. For many people, the first steps are regular physical activity, resistance training, a fiber-rich eating pattern, weight loss when appropriate, better sleep, smoking cessation, and review of medications that may worsen metabolic risk.
Insulin sensitivity can improve for many people, especially with lifestyle changes and weight loss when appropriate. The word “reversed” can be oversimplified because risk can return if the underlying drivers return.
You cannot confirm insulin resistance at home. You can track waist size, blood pressure, weight trend, sleep, activity, and symptoms, then ask a clinician about A1C, fasting glucose, lipids, and other testing.
It may feel like nothing. Some people notice fatigue after meals, cravings, weight gain, or low energy, but these symptoms are nonspecific and can come from many causes.
No. Insulin resistance can happen before blood sugar becomes abnormal. Prediabetes and type 2 diabetes can develop later if the pancreas can no longer keep glucose in range.
Yes. Blood sugar can stay normal for a while if the pancreas makes extra insulin. That is one reason risk factors and metabolic labs matter even when a single glucose reading looks normal.
GLP-1 and GIP/GLP-1 medications are used for specific weight and glucose-related indications in eligible patients, not as a home test or universal treatment for insulin resistance. Compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data.
References
- 1.National Institute of Diabetes and Digestive and Kidney Diseases. Insulin Resistance & Prediabetes. NIDDK, 2024.
- 2.Li M, Chi X, Wang Y, et al. The crucial role and mechanism of insulin resistance in metabolic disease. Frontiers in Endocrinology, 2023.
- 3.Church TJ, Haines ST. Treatment approach to patients with severe insulin resistance. Clinical Diabetes, 2016.
- 4.Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 2013.
- 5.Tauqir S, Israr M, Rauf B, et al. Acetyl-L-carnitine ameliorates metabolic and endocrine alterations in women with PCOS: a double-blind randomized clinical trial. Advances in Therapy, 2021.
- 6.Hatami A, Seidi F, Khosrowbeygi A, et al. The effect of Vitex agnus-castus plant on some markers of oxidative stress, lipid profile and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind controlled clinical trial study. JBRA Assisted Reproduction, 2026.
- 7.Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 2002.
- 8.American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026. Diabetes Care, 2026.
- 9.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information, 2024.
- 10.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information, 2025.
- 11.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information, 2025.
- 12.U.S. Food and Drug Administration. Rybelsus (semaglutide) tablets prescribing information, 2024.
- 13.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information, 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
